This is a Validated Antibody Database (VAD) review about mouse Maml2, based on 4 published articles (read how Labome selects the articles), using Maml2 antibody in all methods. It is aimed to help Labome visitors find the most suited Maml2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Maml2 synonym: 5930431H10; BC032967

Knockout validation
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 3s2c
Cell Signaling Technology Maml2 antibody (CST, 4618) was used in western blot knockout validation on mouse samples at 1:1000 (fig 3s2c). elife (2020) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology Maml2 antibody (Cell Signaling Technology, 4618) was used in western blot on human samples (fig 1a). Signal Transduct Target Ther (2021) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 3s2c
Cell Signaling Technology Maml2 antibody (CST, 4618) was used in western blot knockout validation on mouse samples at 1:1000 (fig 3s2c). elife (2020) ncbi
domestic rabbit monoclonal (D41E6)
  • western blot; mouse; 1:1000; loading ...; fig s12c
In order to investigate the impact of locked nucleic acid-modified antisense oligonucleotide complementary to the CAG repeat on Huntington's disease, Cell Signaling Technology Maml2 antibody (Cell Signaling, 6988) was used in western blot on mouse samples at 1:1000 (fig s12c). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (D41E6)
  • western blot; human; 1:500
In order to investigate the signalling pathways involved in the development of invasive trophoblasts, Cell Signaling Technology Maml2 antibody (Cell Signalling, 6988) was used in western blot on human samples at 1:500. Mol Hum Reprod (2014) ncbi
Articles Reviewed
  1. Ni W, Chen Z, Zhou X, Yang R, Yu M, Lu J, et al. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma. Signal Transduct Target Ther. 2021;6:27 pubmed publisher
  2. Kuang Y, Golan O, Preusse K, Cain B, Christensen C, Salomone J, et al. Enhancer architecture sensitizes cell specific responses to Notch gene dose via a bind and discard mechanism. elife. 2020;9: pubmed publisher
  3. Rue L, Bañez Coronel M, Creus Muncunill J, Giralt A, Alcalá Vida R, Mentxaka G, et al. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels. J Clin Invest. 2016;126:4319-4330 pubmed publisher
  4. Velicky P, Haider S, Otti G, Fiala C, Pollheimer J, Knöfler M. Notch-dependent RBPJ? inhibits proliferation of human cytotrophoblasts and their differentiation into extravillous trophoblasts. Mol Hum Reprod. 2014;20:756-66 pubmed publisher